Transcatheter  ||| S:0 E:14 ||| FW
aortic  ||| S:14 E:21 ||| FW
valve  ||| S:21 E:27 ||| FW
implantation  ||| S:27 E:40 ||| FW
and  ||| S:40 E:44 ||| FW
cerebrovascular  ||| S:44 E:60 ||| FW
accidents  ||| S:60 E:70 ||| FW
Transcatheter  ||| S:70 E:84 ||| FW
aortic  ||| S:84 E:91 ||| FW
valve  ||| S:91 E:97 ||| FW
implantation  ||| S:97 E:110 ||| FW
( ||| S:110 E:111 ||| -LRB-
TAVI ||| S:111 E:115 ||| NNP
)  ||| S:115 E:117 ||| -RRB-
is  ||| S:117 E:120 ||| VBZ
an  ||| S:120 E:123 ||| DT
evidence-based  ||| S:123 E:138 ||| JJ
treatment  ||| S:138 E:148 ||| NN
alternative  ||| S:148 E:160 ||| NN
for  ||| S:160 E:164 ||| IN
selected  ||| S:164 E:173 ||| JJ
high-risk  ||| S:173 E:183 ||| JJ
patients  ||| S:183 E:192 ||| NNS
with  ||| S:192 E:197 ||| IN
symptomatic  ||| S:197 E:209 ||| JJ
severe  ||| S:209 E:216 ||| JJ
aortic  ||| S:216 E:223 ||| NNS
stenosis  ||| S:223 E:232 ||| VBP
as  ||| S:232 E:235 ||| RB
acknowledged  ||| S:235 E:248 ||| VBD
in  ||| S:248 E:251 ||| IN
the  ||| S:251 E:255 ||| DT
most  ||| S:255 E:260 ||| RBS
recent  ||| S:260 E:267 ||| JJ
edition  ||| S:267 E:275 ||| NN
of  ||| S:275 E:278 ||| IN
the  ||| S:278 E:282 ||| DT
ESC  ||| S:282 E:286 ||| NNP
Guidelines  ||| S:286 E:297 ||| NNP
on  ||| S:297 E:300 ||| IN
Valvular  ||| S:300 E:309 ||| NNP
Heart  ||| S:309 E:315 ||| NNP
Disease  ||| S:315 E:323 ||| NNP
2012 ||| S:323 E:327 ||| CD
.  ||| S:327 E:329 ||| .
However ||| S:329 E:336 ||| RB
,  ||| S:336 E:338 ||| ,
periprocedural  ||| S:338 E:353 ||| JJ
complications  ||| S:353 E:367 ||| NNS
and  ||| S:367 E:371 ||| CC
in  ||| S:371 E:374 ||| IN
particular  ||| S:374 E:385 ||| JJ
cerebrovascular  ||| S:385 E:401 ||| JJ
accidents  ||| S:401 E:411 ||| NNS
remain  ||| S:411 E:418 ||| VBP
a  ||| S:418 E:420 ||| DT
matter  ||| S:420 E:427 ||| NN
of  ||| S:427 E:430 ||| IN
concern ||| S:430 E:437 ||| NN
.  ||| S:437 E:439 ||| .
While  ||| S:439 E:445 ||| IN
transcatheter  ||| S:445 E:459 ||| JJ
heart  ||| S:459 E:465 ||| NN
valve  ||| S:465 E:471 ||| NN
technology  ||| S:471 E:482 ||| NN
continuously  ||| S:482 E:495 ||| RB
improves  ||| S:495 E:504 ||| VBZ
and  ||| S:504 E:508 ||| CC
the  ||| S:508 E:512 ||| DT
development  ||| S:512 E:524 ||| NN
of  ||| S:524 E:527 ||| IN
novel  ||| S:527 E:533 ||| NN
and  ||| S:533 E:537 ||| CC
even  ||| S:537 E:542 ||| RB
less  ||| S:542 E:547 ||| RBR
invasive  ||| S:547 E:556 ||| JJ
implantation  ||| S:556 E:569 ||| NN
techniques  ||| S:569 E:580 ||| NNS
is  ||| S:580 E:583 ||| VBZ
on-going ||| S:583 E:591 ||| JJ
,  ||| S:591 E:593 ||| ,
cerebrovascular  ||| S:593 E:609 ||| JJ
events  ||| S:609 E:616 ||| NNS
complicating  ||| S:616 E:629 ||| VBD
TAVI  ||| S:629 E:634 ||| NNP
may  ||| S:634 E:638 ||| MD
abrogate  ||| S:638 E:647 ||| VB
the  ||| S:647 E:651 ||| DT
usual  ||| S:651 E:657 ||| JJ
improvement  ||| S:657 E:669 ||| NN
in  ||| S:669 E:672 ||| IN
terms  ||| S:672 E:678 ||| NNS
of  ||| S:678 E:681 ||| IN
prognosis  ||| S:681 E:691 ||| NN
and  ||| S:691 E:695 ||| CC
quality  ||| S:695 E:703 ||| NN
of  ||| S:703 E:706 ||| IN
life ||| S:706 E:710 ||| NN
.  ||| S:710 E:712 ||| .
This  ||| S:712 E:717 ||| DT
article  ||| S:717 E:725 ||| NN
describes  ||| S:725 E:735 ||| VBZ
the  ||| S:735 E:739 ||| DT
incidence  ||| S:739 E:749 ||| NN
of  ||| S:749 E:752 ||| IN
cerebrovascular  ||| S:752 E:768 ||| JJ
events  ||| S:768 E:775 ||| NNS
after  ||| S:775 E:781 ||| IN
cardiovascular  ||| S:781 E:796 ||| JJ
procedures ||| S:796 E:806 ||| NNS
,  ||| S:806 E:808 ||| ,
provides  ||| S:808 E:817 ||| VBZ
an  ||| S:817 E:820 ||| DT
overview  ||| S:820 E:829 ||| NN
of  ||| S:829 E:832 ||| IN
the  ||| S:832 E:836 ||| DT
pathophysiological  ||| S:836 E:855 ||| JJ
mechanisms  ||| S:855 E:866 ||| NNS
as  ||| S:866 E:869 ||| IN
well  ||| S:869 E:874 ||| RB
as  ||| S:874 E:877 ||| IN
the  ||| S:877 E:881 ||| DT
impact  ||| S:881 E:888 ||| NN
on  ||| S:888 E:891 ||| IN
outcomes  ||| S:891 E:900 ||| NNS
and  ||| S:900 E:904 ||| CC
provides  ||| S:904 E:913 ||| VBZ
some  ||| S:913 E:918 ||| DT
insights  ||| S:918 E:927 ||| NNS
into  ||| S:927 E:932 ||| IN
preventive  ||| S:932 E:943 ||| JJ
strategies  ||| S:943 E:954 ||| NNS
as  ||| S:954 E:957 ||| IN
well  ||| S:957 E:962 ||| RB
as  ||| S:962 E:965 ||| IN
the  ||| S:965 E:969 ||| DT
acute  ||| S:969 E:975 ||| JJ
management  ||| S:975 E:986 ||| NN
of  ||| S:986 E:989 ||| IN
these  ||| S:989 E:995 ||| DT
events ||| S:995 E:1001 ||| NNS
.  ||| S:1001 E:1003 ||| .
